AP2005003347A0 - HPV-16 and-18 Lu VLP vaccine - Google Patents

HPV-16 and-18 Lu VLP vaccine

Info

Publication number
AP2005003347A0
AP2005003347A0 AP2005003347A AP2005003347A AP2005003347A0 AP 2005003347 A0 AP2005003347 A0 AP 2005003347A0 AP 2005003347 A AP2005003347 A AP 2005003347A AP 2005003347 A AP2005003347 A AP 2005003347A AP 2005003347 A0 AP2005003347 A0 AP 2005003347A0
Authority
AP
ARIPO
Prior art keywords
hpv
vlp vaccine
vlp
vaccine
Prior art date
Application number
AP2005003347A
Other languages
English (en)
Inventor
Martine Anne Decil Wettendorff
Bruce Et Al Innis
Original Assignee
Glayosmithkline Biolog S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glayosmithkline Biolog S A filed Critical Glayosmithkline Biolog S A
Publication of AP2005003347A0 publication Critical patent/AP2005003347A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20023—Virus like particles [VLP]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AP2005003347A 2002-12-20 2003-12-18 HPV-16 and-18 Lu VLP vaccine AP2005003347A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US43503502P 2002-12-20 2002-12-20
US49665303P 2003-08-20 2003-08-20
PCT/EP2003/014562 WO2004056389A1 (en) 2002-12-20 2003-12-18 Hpv-16 and -18 l1 vlp vaccine

Publications (1)

Publication Number Publication Date
AP2005003347A0 true AP2005003347A0 (en) 2005-06-30

Family

ID=32685362

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2005003347A AP2005003347A0 (en) 2002-12-20 2003-12-18 HPV-16 and-18 Lu VLP vaccine

Country Status (28)

Country Link
US (2) US20060251676A1 (cg-RX-API-DMAC10.html)
EP (1) EP1572233B1 (cg-RX-API-DMAC10.html)
JP (1) JP5475939B2 (cg-RX-API-DMAC10.html)
KR (3) KR101361769B1 (cg-RX-API-DMAC10.html)
AP (1) AP2005003347A0 (cg-RX-API-DMAC10.html)
AR (1) AR042530A1 (cg-RX-API-DMAC10.html)
AT (1) ATE503492T1 (cg-RX-API-DMAC10.html)
AU (1) AU2003293942B2 (cg-RX-API-DMAC10.html)
BE (3) BE2015C069I2 (cg-RX-API-DMAC10.html)
BR (1) BR0317544A (cg-RX-API-DMAC10.html)
CA (1) CA2510457C (cg-RX-API-DMAC10.html)
CY (1) CY1111552T1 (cg-RX-API-DMAC10.html)
DE (1) DE60336581D1 (cg-RX-API-DMAC10.html)
DK (1) DK1572233T3 (cg-RX-API-DMAC10.html)
EA (2) EA200701633A1 (cg-RX-API-DMAC10.html)
EC (1) ECSP055869A (cg-RX-API-DMAC10.html)
IL (1) IL169085A (cg-RX-API-DMAC10.html)
IS (1) IS2811B (cg-RX-API-DMAC10.html)
MA (1) MA27581A1 (cg-RX-API-DMAC10.html)
MX (1) MXPA05006764A (cg-RX-API-DMAC10.html)
MY (1) MY144492A (cg-RX-API-DMAC10.html)
NO (1) NO20052846L (cg-RX-API-DMAC10.html)
NZ (1) NZ540811A (cg-RX-API-DMAC10.html)
OA (1) OA13147A (cg-RX-API-DMAC10.html)
PL (1) PL215257B1 (cg-RX-API-DMAC10.html)
PT (1) PT1572233E (cg-RX-API-DMAC10.html)
TW (1) TWI349557B (cg-RX-API-DMAC10.html)
WO (1) WO2004056389A1 (cg-RX-API-DMAC10.html)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1126876T1 (sl) 1998-10-16 2007-08-31 Glaxosmithkline Biolog Sa Adjuvantni sistemi in vakcine
GB0206360D0 (en) 2002-03-18 2002-05-01 Glaxosmithkline Biolog Sa Viral antigens
US7858098B2 (en) 2002-12-20 2010-12-28 Glaxosmithkline Biologicals, S.A. Vaccine
US7758866B2 (en) 2004-06-16 2010-07-20 Glaxosmithkline Biologicals, S.A. Vaccine against HPV16 and HPV18 and at least another HPV type selected from HPV 31, 45 or 52
RU2420313C2 (ru) * 2004-06-16 2011-06-10 ГлаксоСмитКлайн Байолоджикалз с.а. Вакцина против вирусов папилломы человека hpv 16 и hpv 18 и по меньшей мере еще одного типа hpv, выбранного из hpv 31, 45 или 52
EP1877087B1 (en) 2005-04-15 2013-02-20 GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Methods and compositions for producing an enhanced immune response to a human papillomavirus immunogen
MX2007013472A (es) * 2005-04-26 2008-04-02 Glaxosmithkline Biolog Sa Vacuna.
MX2007013475A (es) * 2005-04-26 2008-04-02 Glaxosmithkline Biolog Sa Vacuna.
CN101570571B (zh) 2007-04-29 2012-07-11 北京万泰生物药业股份有限公司 截短的人乳头瘤病毒18型l1蛋白
CN101293918B (zh) 2007-04-29 2013-03-27 北京万泰生物药业股份有限公司 截短的人乳头瘤病毒16型l1蛋白
EP2403507B1 (en) * 2009-03-05 2018-02-21 McCloskey, Jenny Colleen Treatment of infection
CN102215861B (zh) * 2009-06-19 2014-10-08 艾金株式会社 宫颈癌疫苗
CN106461667A (zh) 2014-01-31 2017-02-22 乌利塞生物医药公司 用于检测感染及相关病症的生物传感器
CN107001430A (zh) 2014-10-24 2017-08-01 哈普威克斯有限责任公司 癌症和皮肤病变治疗
US10799574B2 (en) 2014-10-24 2020-10-13 Hpvvax. Llc Method and composition for treating cancer or skin lesion using a vaccine
CA2987864C (en) * 2015-06-02 2020-08-18 Terumo Kabushiki Kaisha Adjuvant composition containing aluminum and vaccine composition containing the same
IL277128B2 (en) 2018-03-06 2025-11-01 Precigen Inc Hepatitis b vaccines and uses of the same
JP7581048B2 (ja) * 2018-03-06 2024-11-12 プレシゲン，インコーポレイテッド ヒトパピローマウイルスワクチンおよびその使用
US11771754B2 (en) * 2018-06-04 2023-10-03 Xiamen University Mutant of L1 protein of human papillomavirus type 18
EP3891123A4 (en) 2018-12-03 2022-12-14 Board of Regents, The University of Texas System OLIGO-BENZAMIDE ANALOGS AND THEIR USE IN THE TREATMENT OF CANCER

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4332596A1 (de) * 1993-09-24 1995-03-30 Martin Josef Dr Sapp Monoklonale Antikörper
ES2572628T3 (es) 1997-09-05 2016-06-01 Medimmune, Inc. Método in vitro para desmontaje/remontaje de partículas análogas al virus del papiloma humano (VLP)
DE60040727D1 (de) * 1999-02-05 2008-12-18 Merck & Co Inc Menschliche papillomavirus impfstoff-formulierungen
US6245568B1 (en) 1999-03-26 2001-06-12 Merck & Co., Inc. Human papilloma virus vaccine with disassembled and reassembled virus-like particles
GB9921146D0 (en) * 1999-09-07 1999-11-10 Smithkline Beecham Biolog Novel composition
US6908613B2 (en) * 2000-06-21 2005-06-21 Medimmune, Inc. Chimeric human papillomavirus (HPV) L1 molecules and uses therefor
PT1296711E (pt) * 2000-06-26 2006-08-31 Stressgen Biotechnologies Corp E7 de vph para o tratamento do virus do papiloma humano

Also Published As

Publication number Publication date
BE2015C067I2 (cg-RX-API-DMAC10.html) 2024-08-08
MA27581A1 (fr) 2005-10-03
AU2003293942B2 (en) 2009-12-10
DE60336581D1 (de) 2011-05-12
WO2004056389A1 (en) 2004-07-08
BR0317544A (pt) 2005-11-22
NO20052846L (no) 2005-07-13
MY144492A (en) 2011-09-30
KR20120123616A (ko) 2012-11-08
CA2510457A1 (en) 2004-07-08
DK1572233T3 (da) 2011-06-27
EA200701633A1 (ru) 2007-12-28
BE2015C068I2 (cg-RX-API-DMAC10.html) 2024-08-08
CA2510457C (en) 2011-12-06
KR101361769B1 (ko) 2014-02-10
KR20050086924A (ko) 2005-08-30
PL377710A1 (pl) 2006-02-06
TWI349557B (en) 2011-10-01
EA200500834A1 (ru) 2006-02-24
JP2006512413A (ja) 2006-04-13
ATE503492T1 (de) 2011-04-15
JP5475939B2 (ja) 2014-04-16
NZ540811A (en) 2007-03-30
IL169085A (en) 2014-04-30
MXPA05006764A (es) 2005-09-08
PT1572233E (pt) 2011-06-07
AU2003293942A1 (en) 2004-07-14
IS2811B (is) 2012-11-15
PL215257B1 (pl) 2013-11-29
KR20120118087A (ko) 2012-10-25
ECSP055869A (es) 2005-09-20
US20050287161A1 (en) 2005-12-29
IL169085A0 (en) 2007-07-04
HK1085378A1 (en) 2006-08-25
BE2015C069I2 (cg-RX-API-DMAC10.html) 2024-08-08
EP1572233A1 (en) 2005-09-14
IS7885A (is) 2005-06-09
CY1111552T1 (el) 2015-08-05
TW200423957A (en) 2004-11-16
OA13147A (en) 2006-12-13
US20060251676A1 (en) 2006-11-09
EA009179B1 (ru) 2007-12-28
AR042530A1 (es) 2005-06-22
EP1572233B1 (en) 2011-03-30

Similar Documents

Publication Publication Date Title
AP2005003347A0 (en) HPV-16 and-18 Lu VLP vaccine
GB0226722D0 (en) Vaccine
GB0202901D0 (en) Novel vaccine
GB0329146D0 (en) Vaccine
GB0225788D0 (en) Vaccine
GB0225786D0 (en) Vaccine
GB0218921D0 (en) Novel vaccine
GB0228715D0 (en) Vaccine
GB0209878D0 (en) Vaccine
PL376534A1 (pl) Szczepionka
PL2272532T3 (pl) Szczepionka rotawirusowa
GB0305794D0 (en) Vaccine
GB0305793D0 (en) Vaccine
SI1660123T1 (sl) Cepivo proti rotavirusom
GB0206595D0 (en) Vaccine
IL156434A0 (en) Vaccine
GB0223355D0 (en) Vaccine
GB0226179D0 (en) Vaccine
GB0215621D0 (en) Improved poxvirus vaccines
TW557968U (en) Multi-functional sucker hook
GB0230170D0 (en) Vaccine
GB0227619D0 (en) Vaccine
GB0218036D0 (en) Vaccine
GB0219626D0 (en) Vaccine
GB0220212D0 (en) Vaccine